v3.26.1
Related Parties (Details) - USD ($)
$ in Thousands
12 Months Ended
Apr. 20, 2023
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Jul. 24, 2020
Related Party Transaction [Line Items]            
Share of losses from equity method investments   $ 0 $ 0 $ (383)    
Goodwill   8,731,689 9,051,410 9,022,075 $ 8,971,670  
Acquisition-related gain   0 0 6,160    
Oncacare            
Related Party Transaction [Line Items]            
Majority voting share capital acquired (in percent) 51.00%          
Business combination, consideration transferred $ 5,100          
Goodwill 13,400          
Acquisition-related gain $ 6,200          
Oncacare            
Related Party Transaction [Line Items]            
Equity method investments           $ 4,900
Equity method investment, ownership percentage           49.00%
Corvus Pharmaceuticals | Subsidiaries            
Related Party Transaction [Line Items]            
Revenues   400 300 200    
Other receivables   100 100 100    
Afimmune Limited | Subsidiaries            
Related Party Transaction [Line Items]            
Revenues   0 0 50    
Other receivables   $ 100 $ 100 $ 50